Titanium(IV) oxide, ROTI®nanoMETIC, min. 99.9%, 4-8 nm, 10 g, glass packaging

Methyl (6-(propylsulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate, 97%, 5g

2',5'-Dimethylacetophenone, 98.0%, 100g

(R)-1-(Pyridin-3-ylmethyl)pyrrolidin-3-amine trihydrochloride, 95.0%, 1g

5-(2-OXASPIRO[3.3]HEPTANE-6-YL)-1H-PYRAZOL-3-YLAMINE, 95.0%, 250mg

BOC-DAP(Fmoc)-OH, 95.0%, 10g

2-(Benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)1g

Na-Z-L-histidine methyl ester, 98.0%, 1g

(4-Bromopyridin-3-yl)methanol, 95.0%, 100mg

(2,1,3-Benzothiadiazol-4-yl)methanamine hydrochloride, 95+%, 250mg

(2-(Methoxycarbonyl)-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

5-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-amine, 95.0%, 100g

(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid, 25mg